Shimadzu Medical Systems USA announced the availability of T-smart, a new tomographic image reconstruction function using iterative reconstruction. The algorithm improves the clarity of tomosynthesis-acquired orthopedic images containing metal implanted objects such as used in orthopedics. T-smart made its U.S. debut at the 2015 Association for Medical Imaging Management (AHRA) annual meeting of radiology hospital administrators, held July 19-22 in Las Vegas.
Dramatic increases in pediatric emergency department visits for sports-related head injuries over the past decade are leading to high numbers of unnecessary computed tomography (CT) scans, according to new research. The aggregate result of this increase is higher radiation exposure and higher cost of treatment.
Researchers at the University of Kentucky’s Sanders-Brown Center on Aging are on the hunt for biomarkers that might serve as an early warning system for Alzheimer’s disease (AD).
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
July 31, 2015 — The American Society of Echocardiography (ASE) released a new document describing various imaging ...
Joseph Deasy, Ph.D., discusses his study on dose-volume relations for late rectal bleeding in 1,001 patients from five ...
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
After a tornado decimated the hospital only four years ago, Mercy Hospital Joplin in Joplin, Missouri, reopened its doors in March with a new, 900,000-square-foot facility with state-of-the-art equipment. Part of the acquisition by Mercy Hospital Joplin, formerly St. John’s Regional Medical Center, included eight Aplio 300 Platinum ultrasound systems from Toshiba America Medical Systems Inc.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Navidea Biopharmaceuticals Inc. announced plans to move forward with a joint study of the ability of Tc99m-tilmanocept, a Manocept platform product, to localize in high-risk atherosclerotic plaques. The study — funded through a $321,000 Phase 1 Small Business Innovation Research (SBIR) grant from the National Heart, Lung and Blood Institute (NHLBI), National Institute of Health (NIH) — will be conducted with Massachusetts General Hospital (MGH) and Harvard Medical School.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Breast biopsy systems are used to take tissue samples of suspected cancer inside the breast for pathology testing.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Researchers funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have developed two near-infrared (NIR) contrast agents that are efficiently taken up by the thyroid and parathyroid glands following intravenous injection. The researchers tested the contrast agents in rats and pigs and showed that they could be used to help distinguish the thyroid and parathyroid glands from surrounding tissue and from each other. Their findings appeared in the Jan. 5, 2015, issue of Nature Medicine.
Teams at the Willis-Knighton Cancer Center in Shreveport, Louisiana, have achieved high levels of quality care, ease of use and speed of treatment in 11 months on IBA’s Proteus One compact proton therapy system.
Epsilon Imaging Inc. announced that several studies were presented at the American Society of Echocardiography (ASE) 2015 conference, June 13-16, on its EchoInsight automated measurement suite for improved analysis and interpretation in echo.
The American Society of Radiologic Technologists (ASRT) has opened the ASRT Museum and Archives, a 4,500-square-foot museum devoted to collecting, preserving and sharing the radiologic technology profession's rich history.
Guerbet announced that it has entered into a definitive agreement under which it will acquire Mallinckrodt's contrast media and delivery systems business ("CMDS").